Wed, February 14, 2018
Tue, February 13, 2018
Mon, February 12, 2018

Liisa Bayko Maintained (VRTX) at Buy with Increased Target to $211 on, Feb 13th, 2018

Liisa Bayko of JMP Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $200 to $211 on, Feb 13th, 2018.

Liisa has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Liisa


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Friday, February 2nd, 2018
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $197 on, Thursday, February 1st, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $191 on, Thursday, February 1st, 2018
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $200 on, Thursday, February 1st, 2018